DDX18 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.222600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.863000E-01
Normal-vs-Stage2
7.052000E-01
Normal-vs-Stage3
1.563960E-01
Normal-vs-Stage4
2.371600E-01
Stage1-vs-Stage2
5.199200E-01
Stage1-vs-Stage3
3.732600E-01
Stage1-vs-Stage4
3.674200E-02
Stage2-vs-Stage3
1.399430E-01
Stage2-vs-Stage4
2.587800E-02
Stage3-vs-Stage4
7.560500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.148000E-01
Normal-vs-AfricanAmerican
8.641000E-01
Normal-vs-Asian
3.239600E-01
Caucasian-vs-AfricanAmerican
3.072600E-01
Caucasian-vs-Asian
2.687800E-01
AfricanAmerican-vs-Asian
1.465610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.456800E-01
Normal-vs-Female
6.087200E-01
Male-vs-Female
9.713400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.586800E-01
Normal-vs-Age(41-60Yrs)
9.332800E-01
Normal-vs-Age(61-80Yrs)
4.914400E-01
Normal-vs-Age(81-100Yrs)
7.482200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.989200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.689000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.736600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.456400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.680400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.693000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.213200E-01
Normal-vs-Daily Drinker
3.792400E-01
Normal-vs-Weekly Drinker
8.008600E-01
Normal-vs-Occasional Drinker
9.560200E-01
Normal-vs-Social Drinker
7.890200E-01
Non Drinker-vs-Daily Drinker
8.382800E-01
Non Drinker-vs-Weekly Drinker
3.038800E-01
Non Drinker-vs-Occasional Drinker
1.131750E-01
Non Drinker-vs-Social Drinker
2.494800E-01
Daily Drinker-vs-Weekly Drinker
3.195400E-01
Daily Drinker-vs-Occasional Drinker
1.403010E-01
Daily Drinker-vs-Social Drinker
2.688000E-01
Weekly Drinker-vs-Occasional Drinker
7.260400E-01
Weekly Drinker-vs-Social Drinker
9.772400E-01
Occasional Drinker-vs-Social Drinker
7.282400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.276400E-01
Normal-vs-Grade 2
7.950400E-01
Normal-vs-Grade 3
7.347800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.697000E-03
Grade 1-vs-Grade 3
3.675000E-03
Grade 1-vs-Grade 4
9.276400E-01
Grade 2-vs-Grade 3
2.313600E-01
Grade 2-vs-Grade 4
7.950400E-01
Grade 3-vs-Grade 4
7.347800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.538800E-01
Normal-vs-NonDiabetic
5.061800E-01
Diabetic-vs-NonDiabetic
9.580600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.174200E-01
Normal-vs-NoPancreatitis
5.737800E-01
Pancreatitis-vs-NoPancreatitis
3.915600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.067200E-01
Normal-vs-N1
7.219800E-01
N0-vs-N1
2.313600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.985600E-01
Normal-vs-TP53-NonMutant
5.448000E-01
TP53-Mutant-vs-TP53-NonMutant
9.829200E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
